2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Stroke
1
Mental Disorders
1
Meningitis
1
Ischemia
1
Hypoxia, Brain
1
Encephalitis
1
Brain Neoplasms
1
Brain Injuries
1
Interventions
ziprasidone
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Vaccines
1
Tranexamic Acid
1
Topotecan
1
Tobramycin
1
Thrombin
1
TachoSil
1
Spironolactone
1
Sevelamer
1
Rocuronium
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Papillomavirus Vaccines
1
Oxycodone
1
Nifedipine
1
Nafcillin
1
Music Therapy
1
Molindone
1
Methylprednisolone
1
Lurasidone Hydrochloride
1
Labetalol
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Haloperidol
1
Gemcitabine
1
Fosfomycin
1
Dialectical Behavior Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Meningitis
×
Dialectical Behavior Therapy
×
Clear all
NCT05393492
2022-05-26
GREMO-LCA
University Hospital, Strasbourg, France
Phase NA
Unknown
77 enrolled